ONQ RESEARCH IS NOW PART OF P95 AFRICA. THIS PAGE IS NO LONGER MONITORED. FOLLOW P95 FOR FUTURE UPDATES AT https://www.linkedin.com/company/p95/ P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases. Headquartered in Belgium, P95's full-service CRO solutions span 5 continents, with 300 staff and experience across 30 countries. P95 is dedicated to delivering flexible, customer-centrical solutions, powered by a team that is passionate about driving positive change in global health. The P95 group has over 25 years of experience and offers a range of high-quality services including: - Clinical Trials Phase I-IV - Epidemiology and RWE - Vaccine Development Consulting - Study Start-up and Regulatory - Clinical Monitoring - Home Nursing - Sample Management - Medical Monitoring - Pharmacovigilance - Data Management - Biostatistics - Medical Writing - Qualitative Research
Looking for a particular OnQ Research employee's phone or email?
The OnQ Research annual revenue was $5.3 million in 2026.
10 people are employed at OnQ Research.
OnQ Research is based in Johannesburg, Gauteng.
The NAICS codes for OnQ Research are [541, 54, 5417].
The SIC codes for OnQ Research are [873, 87].